Pay-for-Delay Settlement-$1.2 Billion Announced May 28,2015
FTC v. Cephalon, Inc., E.D. Pa., No. 2:08-cv-2141
Teva Pharmaceutical Industries Ltd. (Teva) agreed to pay $1.2 billion in a Settlement with the Federal Trade Commission. Teva acquired Cephalon, Inc. in 2012. The settlement resolves claims that Cephalon Inc., hindered generic drug competition.